Status:
COMPLETED
Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery
Lead Sponsor:
Erasme University Hospital
Conditions:
Nociceptive Pain
Goal-directed Therapy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will investigate the potential of guiding remifentanil analgesia during cardiac and vascular surgery in moderate to high risk patients requiring general anesthesia.
Detailed Description
Justification: Moderate-to-high risk cardiovascular surgery is associated with perioperative morbidity and mortality. These patients undergo general anesthesia and often require tight blood pressure ...
Eligibility Criteria
Inclusion
- moderate-to-high risk cardiac or vascular surgery
- ASA 2-4
Exclusion
- chronic arrhythmia (e.g. atrial fibrillation)
- aortic insufficiency
- pacemaker
- implanted defibrillator
- valve surgery
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04137991
Start Date
October 10 2019
End Date
November 1 2021
Last Update
July 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesia Department, Erasme Hospital
Brussels, Belgium